Prostate cancer drug extends life

The new trial demonstrates that patients that take the new drug extend their life with four months. The new discovered drug seems to ease the pain in most of cases.

The drug named Zytiga, was discovered by British scientists at the Institute of Cancer Research (ICR). Zytiga can be applied in up to 80% of cases with aggressive drug-resistant prostate cancer.

'We are thrilled that a drug discovered at The Institute of Cancer Research has been proven to significantly extend life for many men, giving doctors a valuable new treatment option.' said professor Johann de Bono from the ICR and The Royal Marsden, chief trial investigator and lead author.